Weiss Multi-Strategy Advisers’s Impax Laboratories, Inc. IPXL Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-15,000	Closed	-$356K	–	592
2014 Q3	$356K	Sell	15,000 -27,320	-65%	-$700K	0.01%	464
2014 Q2	$1.27M	Sell	42,320 -5,310	-11%	-$143K	0.03%	391
2014 Q1	$1.26M	Sell	47,630 -1,670	-3%	-$41.7K	0.03%	433
2013 Q4	$1.24M	Sell	49,300 -700	-1%	-$15.6K	0.03%	400
2013 Q3	$1.02M	Hold	50,000	–	–	0.02%	409
2013 Q2	$997K	Buy	+50,000	New	+$888K	0.03%	386

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IPXL Position: Q4 2014 in Review

Weiss Multi-Strategy Advisers sold out of Impax Laboratories, Inc. (IPXL) in Q4 2014, closing a stake of 15,000 shares — an estimated $356K sold.

Weiss Multi-Strategy Advisers first reported a position in IPXL in Q2 2013 and held it in 6 quarters. The position peaked at $1.27M in Q2 2014. 178 funds tracked by Wall St. Rank hold IPXL as of Q4 2014.

Weiss Multi-Strategy Advisers reported no remaining Impax Laboratories, Inc. position as of Q4 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 15,000 Impax Laboratories, Inc. shares in Q4 2014, an estimated $356K.
Weiss Multi-Strategy Advisers first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Impax Laboratories, Inc. position peaked at $1.27M in Q2 2014.
178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.